View in EDS HTML Full Text PDF Full Text

The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review.

Saved in:
Bibliographic Details
Title: The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review.
Authors: Park H; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Robinson J; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Flanagan C; King's College Hospital, London, UK., Pawlyn C; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital NHS Foundation Trust, London, UK., Jackson G; Department of Hematology, University of Newcastle, Newcastle, UK., Jones JR; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.; King's College Hospital, London, UK.; East Sussex Healthcare NHS Trust, Kent, UK.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Jan; Vol. 67 (1), pp. 7-16. Date of Electronic Publication: 2025 Sep 29.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41020434
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Park+H%22">Park H</searchLink>; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.; University Hospitals Sussex NHS Foundation Trust, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Robinson+J%22">Robinson J</searchLink>; University Hospitals Sussex NHS Foundation Trust, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Flanagan+C%22">Flanagan C</searchLink>; King's College Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Pawlyn+C%22">Pawlyn C</searchLink>; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Jackson+G%22">Jackson G</searchLink>; Department of Hematology, University of Newcastle, Newcastle, UK.<br /><searchLink fieldCode="AU" term="%22Jones+JR%22">Jones JR</searchLink>; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.; King's College Hospital, London, UK.; East Sussex Healthcare NHS Trust, Kent, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2026 Jan; Vol. 67 (1), pp. 7-16. <i>Date of Electronic Publication: </i>2025 Sep 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41020434
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2025.2560085
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7
    Titles:
      – TitleFull: The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Park H
      – PersonEntity:
          Name:
            NameFull: Robinson J
      – PersonEntity:
          Name:
            NameFull: Flanagan C
      – PersonEntity:
          Name:
            NameFull: Pawlyn C
      – PersonEntity:
          Name:
            NameFull: Jackson G
      – PersonEntity:
          Name:
            NameFull: Jones JR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1